Hai-In shares are investigated by supervision, "swine fever god medicine" farce ends

On the evening of July 26,, Haidian Share (000861.SZ) issued a notice that it had received a "Notice of Investigation" from the China Securities Regulatory Commission and had been investigated for alleged violations of the lawqQD
Since June, the so-called "pig plague vaccine" of Haiin shares has been in the marketA month and a half later, the farce ended with a regulatory investigationqQD
Relevant legal sources told the first financial reporter, "Hai-Indian shares in the case that it has been issued by the Guangdong Securities Regulatory Commission warning letter, but still by the CSRC to further open a case investigation, showing that the CSRC effectively implement the attitude of strict supervision of the capital market, increase the illegal costs of illegal subjects." "
qQDsupervision "bright sword", farce endedqQDon the evening of June 11, Haiin shares announced that the company's team successfully developed "today's polysaccharide injection" and has a patent right, can achieve no less than 92% of the effective prevention of swine fever in AfricaqQD
In the afternoon, Hainan Province's Agriculture and Rural Affairs Department denied the successful development of the African swine fever vaccineqQD
　　As soon as the news came out, with the market public opinion continues to ferment Shenzhen Stock Exchange's concern letter was issued quickly, requiring the company to verify and supplement the disclosure of "current polysaccharide injections" patent type, patent number, patentee, filing time and specific approval status and other information, and provide relevant supporting documents qQD
　　On June 17, Hai-In shares replied to the Shenzhen Stock Exchange self-punching, said that the original announcement of the "vaccine" expression is due to staff negligence, a pen error qQD
　　Paper cover fire, June 22 the company finally in a 40-page announcement admitted: Professor Xu Qitai team developed the current bead polysaccharide injection is not a vaccine, is a variety of southern medicine extracts as the main raw materials, is Chinese medicine and natural pharmaceutical preparations Moreover, "no less than 92% effective prevention" is from overseas news, the company has not officially obtained any relevant patents qQD
　　It is worth noting that the operating results signed by Hai-In shares target the gambling agreement of 10 billion revenue, and the company's subsequent response to the Shenzhen Stock Exchange inquiry still insisted that the current Pearl Company in 2019 to 2021 each year to achieve operating income of 500 million, 5 billion, 10 billion targets in line with caution, high percentage growth in revenue and profit growth is reasonable and achievable qQD
　　On June 24, Hai-In shares received a decision on administrative supervision measures by the Guangzhou Securities Regulatory Commission Three days later, Hainan Province Department of Agriculture and Rural Affairs issued a notice that Hainan Jinzhu Company's new veterinary drug clinical trial sourcing, in the absence of the corresponding administrative license or without the record, the company may not carry out clinical trials in any name without authorization qQD
　　On July 26, Haidian Ag announced that it had received the CSRC's Notice of Investigation qQD
　　Why is it being investigated? qQD
　　Throughout this month-and-a-half of farce, shares of Haidian shares have surged to their highest level in a year and a half Beijing Yingke (Shanghai) law firm, Cai Xiang, a lawyer told First Financial Reporter, "Hai-Indian shares this is a typical hot anti-injury themselves, its behavior should have constituted a violation of information disclosure violations." "
qQD in fact, Shenzhen Stock Exchange in its previous concerns also pointed out whether the company has a hot spot or speculation in the stock price motivation qQD
　　Data show that since the first announcement of the shares of India announced the "swine plague vaccine", the company's share price has been rising qQD
　　From June 11 to June 25, the company's share price rose 24.65 percent, hitting a peak of 3.54 yuan per share, its highest since November 8, 2017 qQD
　　With the company's "original form", after receiving the Guangzhou Securities Regulatory Commission's decision on administrative supervision measures, the company's share price all the way down As of July 26, Haidian shares closed down 0.74 percent at 2.69 yuan a share qQD
　　On June 26th the company's shares fell to 3.05 yuan, according to the company's shares On the same day, the dragon and tiger list data show that the top five seats sold are brokerage business department, a total of 3.4113 million yuan sold, the net sale of 152.954 billion yuan Among them, Haitong Securities LishuiCheng East Road Business Department seatsold 14.1371 million yuan, accounting for 8.37 percent of the total turnover of the day qQD
　　On the same day that the disclosure of The Indo-Indian shares was announced as a result of the investigation into the case On the evening of July 26, a spokesman for the CSRC said that the market and investors reflected the legal provisions of the law is too light, intermediaries are not diligent lying to investigate the non-compliance and other issues objective existence, the CSRC is working with relevant parties to promote as soon as possible to amend and improve the relevant provisions of the Securities Law, the proposed issuer, listed companies and their controlling shareholders, the actual controller of false information disclosure, and accounting firms, sponsors and other intermediaries are not diligent and due diligence, and other securities violations, substantially increase the maximum prison term and fines, fines, qQD
　　As of March 31, 2019, the number of common shareholders of Haiin shares reached 886,000, according to the first-quarter report of Haiin Shares qQD
　　As for whether ordinary investors can carry out rights litigation, Mr Cai said, "The current securities law has not yet been revised, according to the principle of non-retroactivity of the law, the penalty for hai-indian shares is a big probability or within the existing standard of punishment." If the investor suffers losses as a result of the hai-Indian swine fever drug incident, after the subsequent formal punishment decision of the CSRC is made and announced, he may make a claim to the illegal subjects such as Hai-Indian shares "
qQD on the evening of July 26, Haidian Shares (000861.SZ) issued a notice that it has received the China Securities Regulatory Commission's "Notice of Investigation" and was investigated for alleged violations of the law qQD
　　Since June, the so-called "pig plague vaccine" of Haiin shares has been in the market A month and a half later, the farce ended with a regulatory investigation qQD
　　Relevant legal sources told the first financial reporter, "Hai-Indian shares in the case that it has been issued by the Guangdong Securities Regulatory Commission warning letter, but still by the CSRC to further open a case investigation, showing that the CSRC effectively implement the attitude of strict supervision of the capital market, increase the illegal costs of illegal subjects." "
qQD supervision "bright sword", farce ended qQD on the evening of June 11, Haiin shares announced that the company's team successfully developed "today's polysaccharide injection" and has a patent right, can achieve no less than 92% of the effective prevention of swine fever in Africa qQD
　　In the afternoon, Hainan Province's Agriculture and Rural Affairs Department denied the successful development of the African swine fever vaccine qQD
　　As soon as the news came out, with the market public opinion continues to ferment Shenzhen Stock Exchange's concern letter was issued quickly, requiring the company to verify and supplement the disclosure of "current polysaccharide injections" patent type, patent number, patentee, filing time and specific approval status and other information, and provide relevant supporting documents qQD
　　On June 17, Hai-In shares replied to the Shenzhen Stock Exchange self-punching, said that the original announcement of the "vaccine" expression is due to staff negligence, a pen error qQD
　　Paper cover fire, June 22 the company finally in a 40-page announcement admitted: Professor Xu Qitai team developed the current bead polysaccharide injection is not a vaccine, is a variety of southern medicine extracts as the main raw materials, is Chinese medicine and natural pharmaceutical preparations Moreover, "no less than 92% effective prevention" is from overseas news, the company has not officially obtained any relevant patents qQD
　　It is worth noting that the operating results signed by Hai-In shares target the gambling agreement of 10 billion revenue, and the company's subsequent response to the Shenzhen Stock Exchange inquiry still insisted that the current Pearl Company in 2019 to 2021 each year to achieve operating income of 500 million, 5 billion, 10 billion targets in line with caution, high percentage growth in revenue and profit growth is reasonable and achievable qQD
　　On June 24, Hai-In shares received a decision on administrative supervision measures by the Guangzhou Securities Regulatory Commission Three days later, Hainan Province Department of Agriculture and Rural Affairs issued a notice that Hainan Jinzhu Company's new veterinary drug clinical trial sourcing, in the absence of the corresponding administrative license or without the record, the company may not carry out clinical trials in any name without authorization qQD
　　On July 26, Haidian Ag announced that it had received the CSRC's Notice of Investigation qQD
　　Why is it being investigated? qQD
　　Throughout this month-and-a-half of farce, shares of Haidian shares have surged to their highest level in a year and a half Beijing Yingke (Shanghai) law firm, Cai Xiang, a lawyer told First Financial Reporter, "Hai-Indian shares this is a typical hot anti-injury themselves, its behavior should have constituted a violation of information disclosure violations." "
qQD in fact, Shenzhen Stock Exchange in its previous concerns also pointed out whether the company has a hot spot or speculation in the stock price motivation qQD
　　Data show that since the first announcement of the shares of India announced the "swine plague vaccine", the company's share price has been rising qQD
　　From June 11 to June 25, the company's share price rose 24.65 percent, hitting a peak of 3.54 yuan per share, its highest since November 8, 2017 qQD
　　With the company's "original form", after receiving the Guangzhou Securities Regulatory Commission's decision on administrative supervision measures, the company's share price all the way down As of July 26, Haidian shares closed down 0.74 percent at 2.69 yuan a share qQD
　　On June 26th the company's shares fell to 3.05 yuan, according to the company's shares On the same day, the dragon and tiger list data show that the top five seats sold are brokerage business department, a total of 3.4113 million yuan sold, the net sale of 152.954 billion yuan Among them, Haitong Securities LishuiCheng East Road Business Department seatsold 14.1371 million yuan, accounting for 8.37 percent of the total turnover of the day qQD
　　On the same day that the disclosure of The Indo-Indian shares was announced as a result of the investigation into the case On the evening of July 26, a spokesman for the CSRC said that the market and investors reflected the legal provisions of the law is too light, intermediaries are not diligent lying to investigate the non-compliance and other issues objective existence, the CSRC is working with relevant parties to promote as soon as possible to amend and improve the relevant provisions of the Securities Law, the proposed issuer, listed companies and their controlling shareholders, the actual controller of false information disclosure, and accounting firms, sponsors and other intermediaries are not diligent and due diligence, and other securities violations, substantially increase the maximum prison term and fines, fines, qQD
　　As of March 31, 2019, the number of common shareholders of Haiin shares reached 886,000, according to the first-quarter report of Haiin Shares qQD
　　As for whether ordinary investors can carry out rights litigation, Mr Cai said, "The current securities law has not yet been revised, according to the principle of non-retroactivity of the law, the penalty for hai-indian shares is a big probability or within the existing standard of punishment." If the investor suffers losses as a result of the hai-Indian swine fever drug incident, after the subsequent formal punishment decision of the CSRC is made and announced, he may make a claim to the illegal subjects such as Hai-Indian shares "
qQD